ImageneBio, Inc.

IMA ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2022

Total Assets: $172.3M

Liabilities Breakdown FY2022

Total Liabilities: $25.3M